Cargando…

Essential Thrombocythaemia with Concomitant Waldenström Macroglobulinaemia: Case Report and Literature Review

Essential thrombocythaemia (ET) and Waldenström macroglobulinaemia (WM) are two distinct disorders. Studies have reported several cases of myeloproliferative neoplasms (MPNs) with concomitant plasma cell dyscrasia. However, there were no reported cases of ET with concomitant WM to date. Here, we pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Nina, Neoh, Chin Loon, Ruan, Zhengying, Zhao, Lei, Ying, Limei, Zhang, Xiaochang, Chen, Sai, Xu, Linglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186880/ https://www.ncbi.nlm.nih.gov/pubmed/32425546 http://dx.doi.org/10.2147/OTT.S245950

Ejemplares similares

Cutaneous Involvement in Waldenström’s Macroglobulinaemia
por: STIEN, Sarah, et al.
Publicado: (2020)

Waldenström macroglobulinaemia presenting as tingling ulcers on the feet
por: Fischer, Isabelle, et al.
Publicado: (2013)

Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
Publicado: (2021)

CANOMAD unmasked by COVID‐19 in a man with Waldenström's macroglobulinaemia
por: Morrison, Hamish D., et al.
Publicado: (2021)

Headache in essential thrombocythaemia
por: Frewin, R, et al.
Publicado: (2012)

Conditional relative survival in Waldenström’s macroglobulinaemia: a population‐based study in The Netherlands
por: Amaador, Karima, et al.
Publicado: (2021)

P1103: OBINUTUZUMAB INDUCTION AND MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINAEMIA
por: Wróbel, Tomasz, et al.
Publicado: (2023)

Systematic literature review of quality‐of‐life questionnaires in Waldenström macroglobulinaemia—need for a disease‐specific tool
por: Bristogiannis, Sotirios, et al.
Publicado: (2023)

Unrecognized pseudohyperkalaemia in essential thrombocythaemia
por: Mannu, Gurdeep Singh, et al.
Publicado: (2011)

Rare presentation of Waldenström’s macroglobulinaemia requiring bilateral above-knee amputations: a case report
por: Deen, Raeed, et al.
Publicado: (2022)

Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy
por: Rankin, Katherine, et al.
Publicado: (2023)

Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis
por: Chan, Wee-Lee, et al.
Publicado: (2023)

Rare lymphomas in routine practice—Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms
por: Knauf, Wolfgang, et al.
Publicado: (2020)

Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia
por: Morrell, Ruth, et al.
Publicado: (2013)

Herbaspirillum huttiense pneumonia in a patient with essential thrombocythaemia
por: Abreu-Di Berardino, Melanie, et al.
Publicado: (2019)

Can post-splenectomy thrombocytosis mask essential thrombocythaemia?
por: Langabeer, Stephen E.
Publicado: (2020)

Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018
por: Amaador, Karima, et al.
Publicado: (2021)

Patient reported outcome measures in Waldenström macroglobulinaemia: A real‐world data analysis from the WMUK Rory Morrison Registry
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia
por: Gotic, Mirjana, et al.
Publicado: (2020)

Follicular Lymphoma Presenting With Monoclonal IgM And MYD88 Mutation: A Case Report And Review Of The Literature
por: Xu, Linglong, et al.
Publicado: (2019)

With M-protein positive, could transthyretin amyloidosis be easily excluded? Not necessarily! Wild-type transthyretin amyloidosis with Waldenström’s macroglobulinaemia: a case report
por: Kinoshita, Haruyuki, et al.
Publicado: (2022)

Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2022)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
por: Mathur, Abhinav, et al.
Publicado: (2022)

Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature
por: Arampatzis, Spyridon, et al.
Publicado: (2010)

P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
por: Uppal, E., et al.
Publicado: (2022)

Bortezomib‐based therapy is effective and well tolerated in frontline and multiply pre‐treated Waldenström macroglobulinaemia including BTKi failures: A real‐world analysis
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Evaluating the screening value of serum light chain ratio, β(2) microglobulin, lactic dehydrogenase and immunoglobulin in patients with multiple myeloma using ROC curves
por: Ying, Limei, et al.
Publicado: (2023)

Nadroparine-induced skin necrosis on a patient with essential thrombocythaemia: a case report
por: Pramateftakis, Manousos-Georgios, et al.
Publicado: (2009)

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing
por: Angona, A, et al.
Publicado: (2016)

Can platelet count be controlled with ticagrelor in patients with essential thrombocythaemia? A case series
por: Yılmaz, Samet, et al.
Publicado: (2023)

Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
por: Moreno, David F., et al.
Publicado: (2022)

P1149: THE EVOLVING STATE OF PLAY IN 1000 PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINAEMIA IN THE UNITED KINGDOM (UK): A REAL-WORLD DATA ANALYSIS FROM THE WMUK RORY MORRISON REGISTRY PROJECT
por: Uppal, E., et al.
Publicado: (2022)

Percutaneous coronary intervention in a patient with heparin resistance due to essential thrombocythaemia: a case report
por: Okabe, Toshitaka, et al.
Publicado: (2021)

Catastrophic antiphospholipid syndrome complicated with essential thrombocythaemia after COVID-19 vaccination: in search of the underlying mechanism
por: Jinno, Sadao, et al.
Publicado: (2021)

Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels
por: Lewandowski, Krzysztof, et al.
Publicado: (2022)

Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80 Years: An Interim Analysis of the EXELS Study
por: Kiladjian, Jean-Jacques, et al.
Publicado: (2012)

Novel lysine‐specific histone demethylase 1 inhibitor in acute myeloid leukaemia transformed from essential thrombocythaemia
por: Hodges, Samantha, et al.
Publicado: (2021)

Streptococcus pneumoniae sepsis in a pleural effusion smear with concomitant Waldenstrom's macroglobulinemia
por: Austein, Thorsten
Publicado: (2015)

Prostaglandin cyclooxygenase products but not thromboxane A(2) are involved in the pathogenesis of ewthromelalgia in thrombocythaemia
por: Michiels, J. J., et al.
Publicado: (1993)

Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera
por: Tiong, I S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_clgteiqpdaqaj5qf94t2bd0ppr